Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • BPA exposure linked to autism spectrum disorder, study reports

  • BPA exposure linked to autism spectrum disorder

  • One step closer to defeating Alzheimer's disease

  • Cerebral blood flow as a possible marker for concussion outcomes

  • Survey of teen dating violence among US high school students

  • Minors easily able to purchase electronic cigarettes online

  • Scientists crack piece of neural code for learning, memory

  • Low sugar uptake in brain appears to exacerbate Alzheimer's disease

  • New assessment tool can predict successful teachers

  • Heart valve repair significantly improves emotional wellbeing in patients with mitral regurgitation

  •